Clinical Trial

"Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4) Gene Single-nucleotide Polymorphism in Primary Immune Thrombocytopenic Purpura in Children"

Study acronym: ITP
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
the investigators aim in this study to investigate the potential association of single gene polymorphisms of CTLA-4 (SNPs; rs: 3087243) using real-time PCR in children with primary ITP.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-03.
Trial Details
NCT Number NCT07014904
Lead Sponsor Sohag University
Conditions ITP - Immune Thrombocytopenia
Enrollment 80 participants
Start Date 2025-08-20
Primary Completion 2027-06-04 (estimated)
Study Completion 2027-07-20 (estimated)
Updated on ClinicalTrials.gov 2025-06-17